Shire plc (SHPG) Boosts Eye Business With $160 Million SARcode Buy
3/25/2013 6:45:16 AM
More...
|
First Subject Enrolled in OPUS-2, SARcode's Second Pivotal Study of Lifitegrast Ophthalmic Solution
1/8/2013 9:54:31 AM
More...
|
SARcode Announces Positive Topline Results From Phase 3 Dry Eye Study of Lifitegrast
10/23/2012 10:13:11 AM
More...
|
SARcode Release: Last Patient Enrolled in Pivotal Phase 3 Dry Eye Study (OPUS-1) of SAR 1118 Ophthalmic Solution
3/5/2012 11:22:03 AM
More...
|
First Patient Enrolled in SARcode's Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution
9/14/2011 11:36:21 AM
More...
|
SARcode Pulls in $44 Million Series B Financing
7/18/2011 6:38:54 AM
More...
|
SARcode's SAR 1118 Demonstrates Encouraging Results in Phase 2 Study of Dry Eye Disease
5/4/2011 7:34:28 AM
More...
|
SARcode to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting
3/24/2011 7:15:09 AM
More...
|
Todd A. Creech Named Chief Financial Officer and Vice President of Business Development for SARcode
2/14/2011 7:01:19 AM
More...
|
Quinton Oswald Named Chief Executive Officer of SARcode
9/14/2010 8:23:20 AM
More...
|
|